Washington, DC - The robot soldiers of the future, so-called “battle bots,” are still in basic training.

Sacramento, California - Governor Edmund G. Brown Jr. today announced the following appointments:

Washington, DC - The National Science Foundation (NSF) is announcing a $1.8 million grant for the initial development of a data storage network over the next two years. A collaborative team will combine their expertise, facilities and research challenges to develop the Open Storage Network (OSN). OSN will enable academic researchers across the nation to work with and share their data more efficiently than ever before.

Washington, DC - The Energy Department launched the American-Made Solar Prize, a $3 million prize competition that aims to spur the next wave of solar technology innovations in the United States. The release of the contest rules marks the official kickoff of the competition.

Washington, DC - We’re encouraged by declines in overall youth tobacco use over the last several years reflected in the 2017 National Youth Tobacco Survey. Protecting our nation’s youth from the dangers of tobacco products is among the U.S. Food and Drug Administration’s most important responsibilities and we’re taking aggressive steps to make sure all tobacco products aren’t being marketed to, sold to, or used by kids. These efforts are a cornerstone of our comprehensive plan announced last summer. They are also the focus of our Youth Tobacco Prevention Plan announced in April. We’re actively examining a policy to prevent future generations from becoming addicted in the first place by rendering cigarettes minimally or non-addictive and taking every opportunity to disrupt the cycle of successive generations of nicotine and tobacco addiction.

Washington, DC - The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company’s president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Ebola. Claims that a hand sanitizer can protect consumers against infection from pathogens are drug claims and therefore, these products are regulated by the FDA as drugs.